BRIEF-Tasly Pharma gets regulatory approval to issue up to 800 mln yuan bonds
* Says it gets securities regulator's approval to issue up to 800 million yuan ($116.98 million) bonds
Oct 18 Pulike Biological Engineering Inc
* Says share trade to resume on Oct 19
Source text in Chinese: bit.ly/2e4cHuR
Further company coverage: (Reporting by Hong Kong newsroom)
FRANKFURT, June 23 European regulators have recommended approval of a second copy of AbbVie's rheumatoid arthritis drug Humira, the world's top-selling medicine, in a further boost for so-called biosimilars in the region.
* Expected to record an increase in net profit attributable to shareholders for period from 1 January 2017 to 30 June 2017